Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Breast 1

Conditions

Lymphoma, B-Cell 1Fatigue 1

Interventions

Therapeutics 4Psychiatric Rehabilitation 3Behavior Therapy 3Surveys and Questionnaires 2Lenalidomide 2Exercise 2Cognitive Behavioral Therapy 2ofatumumab 1Yoga 1Uncertainty 1Therapeutic Touch 1Ritonavir 1Quality of Life 1Psychosocial Intervention 1Physical Therapy Modalities 1Modafinil 1Metformin 1Hypericum extract LI 160 1Exergaming 1Diet Therapy 1Counseling 1Body Composition 1Asian ginseng 1Acceptance and Commitment Therapy 1AIEOP acute lymphoblastic leukemia protocol 14-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Modafinil × Lymphoid × Clear all
NCT01044004 2013-07-23

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

Washington University School of Medicine

Phase NA Withdrawn
Lymphoid

Fatigue, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡